| Michele L'hommedieu, PT | |
|
1367 Washington Ave, Albany, NY 12206-1069 | |
| (518) 438-7926 | |
| (518) 438-8364 |
| Full Name | Michele L'hommedieu |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 33 Years |
| Location | 1367 Washington Ave, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194784330 | NPI | - | NPPES |
| 01941620 | Medicaid | NY | |
| RB1350 | Other | NY | MEDICARE |
| P01290002 | Other | NY | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 012502-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thomas Nicolla Consulting Services Pllc | 7315836848 | 24 |
News Archive
Using a growth factor to stimulate production of circulating endothelial progenitor cells increases the numbers of these vascular regenerative cells, improves mobility, and potentially could improve blood vessel function in patients with peripheral arterial disease (PAD).
Pharmacyclics, Inc. today announced that it has entered into stock purchase agreements with various institutional investors for the sale of approximately 6,150,000 shares of its common stock in a registered direct offering at $6.51 per share, the closing price on June 15, 2010.
A mini-laboratory that makes it possible, among other things, to study how brain cells in stroke patients are affected by lack of oxygen is being developed by a research team at Luleå University of Technology in Sweden. Lab on a Chip is what the scientists are calling their mini-lab, which is expected to facilitate studies of all sorts of biological cells and how they are affected by different medicines, chemical substances, etc.
Los Angeles Times: "After days of delay, Senate Democrats pushed ahead Thursday with their drive to pass a healthcare bill by Christmas, approving the first amendment to their giant bill: a measure to expand women's access to preventive services such as mammograms."
Vitrolife has received approval from the U.S. Food and Drug Administration, FDA, the equivalent of the Swedish Medical Products Agency, for the products RapitVit™ Blast and RapidWarm™ Blast. So-called 510(k) clearance has been obtained for these products, which are used for so-called vitrification, the rapid freezing and thawing of blastocysts (embryos days 5-7 after fertilization). Vitrolife has since before approved products for vitrification of embryos in an earlier stage of the fertilization (embryos day 2-3 after fertilization).
› Verified 7 days ago
| Provider Name | Thomas Nicolla Consulting Services Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1487633152 PECOS PAC ID: 7315836848 Enrollment ID: O20040624000511 |
News Archive
Using a growth factor to stimulate production of circulating endothelial progenitor cells increases the numbers of these vascular regenerative cells, improves mobility, and potentially could improve blood vessel function in patients with peripheral arterial disease (PAD).
Pharmacyclics, Inc. today announced that it has entered into stock purchase agreements with various institutional investors for the sale of approximately 6,150,000 shares of its common stock in a registered direct offering at $6.51 per share, the closing price on June 15, 2010.
A mini-laboratory that makes it possible, among other things, to study how brain cells in stroke patients are affected by lack of oxygen is being developed by a research team at Luleå University of Technology in Sweden. Lab on a Chip is what the scientists are calling their mini-lab, which is expected to facilitate studies of all sorts of biological cells and how they are affected by different medicines, chemical substances, etc.
Los Angeles Times: "After days of delay, Senate Democrats pushed ahead Thursday with their drive to pass a healthcare bill by Christmas, approving the first amendment to their giant bill: a measure to expand women's access to preventive services such as mammograms."
Vitrolife has received approval from the U.S. Food and Drug Administration, FDA, the equivalent of the Swedish Medical Products Agency, for the products RapitVit™ Blast and RapidWarm™ Blast. So-called 510(k) clearance has been obtained for these products, which are used for so-called vitrification, the rapid freezing and thawing of blastocysts (embryos days 5-7 after fertilization). Vitrolife has since before approved products for vitrification of embryos in an earlier stage of the fertilization (embryos day 2-3 after fertilization).
› Verified 7 days ago
| Provider Name | Balanced Health Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1144625401 PECOS PAC ID: 1456672591 Enrollment ID: O20150602000898 |
News Archive
Using a growth factor to stimulate production of circulating endothelial progenitor cells increases the numbers of these vascular regenerative cells, improves mobility, and potentially could improve blood vessel function in patients with peripheral arterial disease (PAD).
Pharmacyclics, Inc. today announced that it has entered into stock purchase agreements with various institutional investors for the sale of approximately 6,150,000 shares of its common stock in a registered direct offering at $6.51 per share, the closing price on June 15, 2010.
A mini-laboratory that makes it possible, among other things, to study how brain cells in stroke patients are affected by lack of oxygen is being developed by a research team at Luleå University of Technology in Sweden. Lab on a Chip is what the scientists are calling their mini-lab, which is expected to facilitate studies of all sorts of biological cells and how they are affected by different medicines, chemical substances, etc.
Los Angeles Times: "After days of delay, Senate Democrats pushed ahead Thursday with their drive to pass a healthcare bill by Christmas, approving the first amendment to their giant bill: a measure to expand women's access to preventive services such as mammograms."
Vitrolife has received approval from the U.S. Food and Drug Administration, FDA, the equivalent of the Swedish Medical Products Agency, for the products RapitVit™ Blast and RapidWarm™ Blast. So-called 510(k) clearance has been obtained for these products, which are used for so-called vitrification, the rapid freezing and thawing of blastocysts (embryos days 5-7 after fertilization). Vitrolife has since before approved products for vitrification of embryos in an earlier stage of the fertilization (embryos day 2-3 after fertilization).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michele L'hommedieu, PT 711 Troy Schenectady Rd, Suite 209, Latham, NY 12110-2442 Ph: (518) 786-1667 | Michele L'hommedieu, PT 1367 Washington Ave, Albany, NY 12206-1069 Ph: (518) 438-7926 |
News Archive
Using a growth factor to stimulate production of circulating endothelial progenitor cells increases the numbers of these vascular regenerative cells, improves mobility, and potentially could improve blood vessel function in patients with peripheral arterial disease (PAD).
Pharmacyclics, Inc. today announced that it has entered into stock purchase agreements with various institutional investors for the sale of approximately 6,150,000 shares of its common stock in a registered direct offering at $6.51 per share, the closing price on June 15, 2010.
A mini-laboratory that makes it possible, among other things, to study how brain cells in stroke patients are affected by lack of oxygen is being developed by a research team at Luleå University of Technology in Sweden. Lab on a Chip is what the scientists are calling their mini-lab, which is expected to facilitate studies of all sorts of biological cells and how they are affected by different medicines, chemical substances, etc.
Los Angeles Times: "After days of delay, Senate Democrats pushed ahead Thursday with their drive to pass a healthcare bill by Christmas, approving the first amendment to their giant bill: a measure to expand women's access to preventive services such as mammograms."
Vitrolife has received approval from the U.S. Food and Drug Administration, FDA, the equivalent of the Swedish Medical Products Agency, for the products RapitVit™ Blast and RapidWarm™ Blast. So-called 510(k) clearance has been obtained for these products, which are used for so-called vitrification, the rapid freezing and thawing of blastocysts (embryos days 5-7 after fertilization). Vitrolife has since before approved products for vitrification of embryos in an earlier stage of the fertilization (embryos day 2-3 after fertilization).
› Verified 7 days ago
Jordan Iris Bakowski, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 900 Watervliet Shaker Rd, Suite 102, Albany, NY 12205 Phone: 518-862-4900 | |
Yuan Kenneth Jin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd Ste 200, Albany, NY 12205 Phone: 518-489-2524 Fax: 518-489-3167 | |
Penelope M Blasch, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-453-2273 | |
Heather M. Lacasse, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd Health Park, Albany, NY 12205 Phone: 518-489-2524 Fax: 518-489-3167 | |
Marianna Vaysman, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 281 Sand Creek Rd, Albany, NY 12205 Phone: 518-459-1292 Fax: 518-459-1296 | |
Kimberly Silvernail Keane, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-453-2273 | |
Dr. Janel Lena Carver, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Clinton Ave Apt 1, Albany, NY 12210 Phone: 914-299-9514 |